Lv4
476 积分 2022-04-28 加入
Lipid nanoparticles produce chimeric antigen receptor macrophages (CAR-M) in situ for the treatment of solid tumors
1天前
已完结
Aptamer-Based Nongenetic Reprogramming of CARs Enables Flexible Modulation of T Cell-Mediated Tumor Immunotherapy
3个月前
已完结
Non-Viral Sleeping Beauty Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic Efficiency
3个月前
已完结
Non-Viral Sleeping Beauty Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic Efficiency
3个月前
已关闭
Nonviral vector system for cancer immunogene therapy
3个月前
已完结
Who wins the combat, CAR or TCR?
3个月前
已完结
Modulating β-catenin homeostasis for cancer therapy
4个月前
已完结
Controlling the biodistribution and clearance of nanomedicines
6个月前
已完结
Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy
6个月前
已完结
Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma
7个月前
已完结
皖公网安备34019202002308
